DE2512247A1
(en)
|
1975-03-20 |
1976-10-14 |
Thomae Gmbh Dr K |
Tablets contg. drying agents - for protection against moisture
|
US4211777A
(en)
|
1977-11-25 |
1980-07-08 |
Fisons Limited |
Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
|
FR2471186A1
(en)
|
1979-12-10 |
1981-06-19 |
Roussel Uclaf |
NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS
|
JPS57500432A
(en)
|
1980-03-20 |
1982-03-11 |
|
|
SE8003805L
(en)
|
1980-05-21 |
1981-11-22 |
Haessle Ab |
A PHARMACEUTICAL PREPARATION WITH IMPROVED EMISSION PROPERTY
|
US4412992A
(en)
|
1980-07-21 |
1983-11-01 |
Biorex Laboratories Limited |
2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
|
NZ198241A
(en)
|
1980-09-27 |
1983-12-16 |
Beecham Group Ltd |
Tablet containing amoxycillin and potassium clavulanate
|
US4312806A
(en)
|
1981-03-02 |
1982-01-26 |
G. D. Searle & Co. |
Method and compounds for treating inflammatory bowel disease
|
ZA825384B
(en)
|
1981-07-31 |
1983-05-25 |
Tillott J B Ltd |
Orally administrable pharmaceutical compositions
|
DE3151196A1
(en)
|
1981-12-23 |
1983-06-30 |
Kurt Heinz Prof. Dr. 7800 Freiburg Bauer |
METHOD FOR PRODUCING EASILY SOLUBLE 5-AMINOSALICYL ACID MEDICAL PREPARATIONS
|
JPS58109413A
(en)
|
1981-12-23 |
1983-06-29 |
Eisai Co Ltd |
Shock-resistant enteric tablet
|
JPS58213073A
(en)
|
1982-06-07 |
1983-12-10 |
Masatoshi Yamada |
Solidification of oily substance
|
US4539198A
(en)
|
1983-07-07 |
1985-09-03 |
Rowell Laboratories, Inc. |
Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
|
SE457505B
(en)
|
1984-01-10 |
1989-01-09 |
Lejus Medical Ab |
LAMINATED ORAL PHARMACEUTICAL COMPOSITION AND PROCEDURES FOR ITS PREPARATION
|
US4552899A
(en)
|
1984-04-09 |
1985-11-12 |
Analgesic Associates |
Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
|
US4678516A
(en)
|
1984-10-09 |
1987-07-07 |
The Dow Chemical Company |
Sustained release dosage form based on highly plasticized cellulose ether gels
|
DK153412C
(en)
|
1984-11-22 |
1988-12-19 |
Ferring A S |
PROCEDURE FOR THE PREPARATION OF P-AMINOPHENOLS BY ELECTROLYSE
|
IL77186A0
(en)
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
SE460945B
(en)
|
1987-01-15 |
1989-12-11 |
Lejus Medical Ab |
A MULTIPLE-UNIT DOS COMPOSITION OF FUROSEMID
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
US5068110A
(en)
|
1987-09-29 |
1991-11-26 |
Warner-Lambert Company |
Stabilization of enteric coated dosage form
|
JP2514078B2
(en)
|
1988-08-22 |
1996-07-10 |
エスエス製薬株式会社 |
Compressed formulation
|
IT1230576B
(en)
*
|
1988-10-20 |
1991-10-28 |
Angeli Inst Spa |
ORAL PHARMACEUTICAL FORMULATIONS WITH SELECTIVE LIBERATION IN THE COLON
|
DE3838094A1
(en)
|
1988-11-10 |
1990-05-17 |
Nordmark Arzneimittel Gmbh |
SOLID PHARMACEUTICAL RETARD FORM
|
DE3907973A1
(en)
|
1989-03-11 |
1990-09-13 |
Merck Patent Gmbh |
DRYER TABLET
|
GB8909559D0
(en)
|
1989-04-26 |
1989-06-14 |
Smith Kline French Lab |
Pharmaceutical compositions
|
US5540945A
(en)
|
1989-05-11 |
1996-07-30 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
|
JPH0383914A
(en)
|
1989-08-18 |
1991-04-09 |
W R Grace & Co |
Drug carrier
|
US5027797A
(en)
|
1989-10-12 |
1991-07-02 |
Horace Bullard |
Apparatus for the movement of blood by external pressure
|
GB8926639D0
(en)
|
1989-11-24 |
1990-01-17 |
Agricultural & Food Res |
Delayed release formulations
|
US5175003A
(en)
|
1990-04-06 |
1992-12-29 |
Biosytes Usa, Inc. |
Dual mechanism controlled release system for drug dosage forms
|
US5018621A
(en)
|
1990-04-16 |
1991-05-28 |
Connell Jr John J O |
Cylindrical container and dispenser for spherical objects
|
IT1246383B
(en)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
METHOD FOR MASKING THE TASTE OF DRUGS
|
IT1246382B
(en)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON
|
JP2773959B2
(en)
|
1990-07-10 |
1998-07-09 |
信越化学工業株式会社 |
Colon release solid preparation
|
SE9003296L
(en)
|
1990-10-16 |
1992-04-17 |
Kabi Pharmacia Ab |
PROCEDURE SHOULD FORMULATE MEDICINAL PRODUCTS
|
US5519014A
(en)
|
1990-10-22 |
1996-05-21 |
Borody; Thomas J. |
Treatment of non-inflammatory and non-infectious bowel disorders
|
US5316772A
(en)
|
1990-12-19 |
1994-05-31 |
Solvay & Cie, S.A. (Societe Anonyme) |
Bilayered oral pharmaceutical composition with pH dependent release
|
GEP19971086B
(en)
|
1991-02-22 |
1997-12-02 |
Tillotts Pharma Ag |
Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
|
US5629012A
(en)
|
1991-06-17 |
1997-05-13 |
Farmaceutisk Laboratorium Ferring A/S |
Process for producing suppositories by compression and suppositories obtained by the process
|
DK0542364T3
(en)
|
1991-11-13 |
1996-03-11 |
Glaxo Canada |
Controlled release device
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5656296A
(en)
|
1992-04-29 |
1997-08-12 |
Warner-Lambert Company |
Dual control sustained release drug delivery systems and methods for preparing same
|
US5837277A
(en)
|
1992-06-04 |
1998-11-17 |
Smithkline Beecham Corporation |
Palatable pharmaceutical compositions
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
US5654004A
(en)
|
1992-11-06 |
1997-08-05 |
Hisamitsu Pharmaceutical Co., Inc. |
Oral pharmaceutical preparation releasable in the lower digestive tract
|
US5656290A
(en)
|
1993-02-26 |
1997-08-12 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
US5914132A
(en)
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
ES2149250T3
(en)
|
1993-04-23 |
2000-11-01 |
Novartis Ag |
DEVICE FOR THE ADMINISTRATION OF MEDICINES WITH CONTROLLED RELEASE.
|
DK66493D0
(en)
|
1993-06-08 |
1993-06-08 |
Ferring A S |
PREPARATIONS FOR USE IN TREATMENT OF INFLAMMATORY GAS DISORDERS OR TO IMPROVE IMPROVED HEALTH
|
JPH072650A
(en)
|
1993-06-18 |
1995-01-06 |
Tanabe Seiyaku Co Ltd |
Release part control type preparation
|
DE4332394A1
(en)
|
1993-09-23 |
1995-03-30 |
Falk Pharma Gmbh |
Controlled release budesonide pellets and method of making the same
|
US5500227A
(en)
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
HU213407B
(en)
|
1993-12-09 |
1997-06-30 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing tablet with diffusive-osmotic release
|
US5482718A
(en)
*
|
1994-03-23 |
1996-01-09 |
Hoffmann-La Roche Inc. |
Colon-targeted delivery system
|
US5536507A
(en)
|
1994-06-24 |
1996-07-16 |
Bristol-Myers Squibb Company |
Colonic drug delivery system
|
DE19511131A1
(en)
|
1995-03-27 |
1996-10-02 |
Basf Ag |
Mechanically stable solid active substance preparation forms
|
WO1996030003A1
(en)
|
1995-03-30 |
1996-10-03 |
Werner Kreutz |
Medicaments for the selective treatment of tumour tissues
|
US5686106A
(en)
|
1995-05-17 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form for colonic delivery
|
US5631245A
(en)
|
1995-06-06 |
1997-05-20 |
Biodynamics Pharmaceuticals, Inc. |
Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
|
US5656294A
(en)
|
1995-06-07 |
1997-08-12 |
Cibus Pharmaceutical, Inc. |
Colonic delivery of drugs
|
US5945124A
(en)
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
FR2738150B1
(en)
|
1995-09-01 |
1997-10-31 |
Synthelabo |
USE OF SULPHASALAZINE AND ITS METABOLITES FOR THE MANUFACTURE OF A MEDICAMENT USEFUL IN THE TREATMENT OF VENOUS INSUFFICIENCY AND VENOUS ULCERS
|
IT1277663B1
(en)
|
1995-09-28 |
1997-11-11 |
Crinos Industria Farmaco |
STABLE AQUEOUS SUSPENSIONS OF MESALAZINE FOR TOPICAL USE
|
CN1155369C
(en)
|
1995-12-21 |
2004-06-30 |
药物实验室费林公司 |
Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases
|
US6004581A
(en)
|
1995-12-21 |
1999-12-21 |
Farmaceutisk Laboratorium Ferring A/S |
Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
|
US6231888B1
(en)
|
1996-01-18 |
2001-05-15 |
Perio Products Ltd. |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
|
JP2000516222A
(en)
|
1996-08-15 |
2000-12-05 |
ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング |
Oral pharmaceutical composition that is easy to swallow
|
EP1006798A4
(en)
|
1996-09-05 |
2003-03-05 |
Massachusetts Inst Technology |
Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
|
CN1239425A
(en)
|
1996-11-15 |
1999-12-22 |
普罗克特和甘保尔公司 |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
WO1998026767A2
(en)
|
1996-12-17 |
1998-06-25 |
Poli Industria Chimica S.P.A. |
Site-specific controlled release dosage formulation for mesalamine
|
WO1998027967A1
(en)
|
1996-12-20 |
1998-07-02 |
Dumex-Alpharma A/S |
Release-controlled coated tablets
|
US5811121A
(en)
|
1997-01-29 |
1998-09-22 |
Eastman Chemical Company |
PH-sensitive coatings based on cellulose acetoacetate
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US20020039594A1
(en)
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
DE19732903A1
(en)
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet formulation for the treatment of the intestinal tract
|
US5895663A
(en)
|
1997-07-31 |
1999-04-20 |
L. Perrigo Company |
Pseudoephedrine hydrochloride extended-release tablets
|
CA2220038A1
(en)
|
1998-01-05 |
1999-07-05 |
Amina Odidi |
Device for the delivery of high dose pharmaceutical, neutraceutical, agricultural, biological, and chemical substances
|
US6365185B1
(en)
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
GB9810181D0
(en)
|
1998-05-13 |
1998-07-08 |
Smithkline Beecham Plc |
Novel formulations
|
ES2197600T3
(en)
|
1999-01-29 |
2004-01-01 |
Disphar International B.V. |
PHARMACEUTICAL COMPOSITIONS.
|
US6326364B1
(en)
|
1999-02-08 |
2001-12-04 |
Cedars-Sinai Medical Center |
Use of 5-aminosalicylates as antimicrobial agents
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
EP1183014B1
(en)
|
1999-06-14 |
2003-10-08 |
Cosmo S.p.A. |
Controlled release and taste masking oral pharmaceutical compositions
|
ITMI991316A1
(en)
|
1999-06-14 |
2000-12-14 |
Cip Ninety Two 92 S A |
ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF MESALAZINE
|
IT1318376B1
(en)
|
2000-03-07 |
2003-08-25 |
Pharmatec Internat S R L |
ORAL SOLID FORMS WITH CONTROLLED RELEASE CONTAINING MESALAZINE AS AN ACTIVE PRINCIPLE.
|
DE10013030A1
(en)
|
2000-03-17 |
2001-09-20 |
Roehm Gmbh |
Formulation for treating ulcerative colitis, comprising active agent, e.g. 5-aminosalicylic acid or prednisone, coated with acrylic copolymer to provide delayed release at high pH in the colon
|
DE10013029A1
(en)
|
2000-03-17 |
2001-09-20 |
Roehm Gmbh |
Multilayer formulation for controlled drug release in colon, comprising drug-containing core having inner and outer coatings of acrylic copolymers with quaternary ammonium and anionic groups respectively
|
SE0001151D0
(en)
|
2000-03-31 |
2000-03-31 |
Amarin Dev Ab |
Method of producing a controlled-release composition
|
WO2001091716A1
(en)
|
2000-05-30 |
2001-12-06 |
Add Advanced Drug Delivery Technologies Ag |
Peroral therapeutic system comprising glipizide
|
US6365209B2
(en)
|
2000-06-06 |
2002-04-02 |
Capricorn Pharma, Inc. |
Confectionery compositions and methods of making
|
DE10029410A1
(en)
|
2000-06-15 |
2002-01-03 |
Bfgoodrich Diamalt Gmbh |
Process for the preparation of 5-aminosalicylic acid
|
IT1318625B1
(en)
|
2000-07-14 |
2003-08-27 |
Roberto Valducci |
ORAL SOLID PHARMACEUTICAL FORMULATIONS WITH MULTI-PHASE RELEASE - EMPLOYEE.
|
DE50013843D1
(en)
|
2000-08-29 |
2007-01-18 |
Mepha Ag |
MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
US20030175349A1
(en)
|
2001-01-30 |
2003-09-18 |
Council Of Scientific And Industrial Research |
Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
|
JP5502254B2
(en)
|
2001-01-31 |
2014-05-28 |
エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Multiparticulate dosage form consisting of at least two different coated pellet forms
|
WO2002085335A1
(en)
|
2001-04-18 |
2002-10-31 |
Nostrum Pharmaceuticals Inc. |
A novel coating for a sustained release pharmaceutical composition
|
US20070059368A1
(en)
|
2005-05-31 |
2007-03-15 |
Cherukuri S R |
Modified release formulations of anti-irritability drugs
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
US20030099711A1
(en)
|
2001-08-29 |
2003-05-29 |
David Meadows |
Sustained release preparations
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
AR036797A1
(en)
|
2001-10-15 |
2004-10-06 |
Ferring Bv |
A METHOD TO PREPARE A PHARMACEUTICAL COMPOSITION THAT INCLUDES 5-AMINOSALICILIC ACID TO USE IN THE TREATMENT OF ULCEROSE COLITIS AND CROHN DISEASES
|
US7815936B2
(en)
|
2001-10-30 |
2010-10-19 |
Evonik Degussa Gmbh |
Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
|
EP1453487B2
(en)
|
2001-11-23 |
2021-03-31 |
Allergan Pharmaceuticals International Limited |
Pharmaceutical dosage form with multiple coatings
|
DE10208335A1
(en)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Pharmaceutical form and process for its preparation
|
FR2837100B1
(en)
|
2002-03-18 |
2004-07-23 |
Flamel Tech Sa |
MODIFIED RELEASE MICROCAPSULE-BASED TABLETS
|
EP1519717B1
(en)
|
2002-07-05 |
2010-09-29 |
Temrel Limited |
Controlled release composition
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
DE10250543A1
(en)
|
2002-10-29 |
2004-05-19 |
Röhm GmbH & Co. KG |
Multilayer dosage form
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
DE10304403A1
(en)
|
2003-01-28 |
2004-08-05 |
Röhm GmbH & Co. KG |
Process for the preparation of an oral dosage form with immediate disintegration and drug release
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
EP1603540A2
(en)
|
2003-03-14 |
2005-12-14 |
Nirmal Mulye |
A process for preparing sustained release tablets
|
WO2004087113A1
(en)
|
2003-04-04 |
2004-10-14 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions for colon specific delivery
|
US7825106B2
(en)
|
2003-09-03 |
2010-11-02 |
Agi Therapeutics Ltd. |
Modified release formulations and methods of treating inflammatory bowel disease
|
MXPA06003100A
(en)
|
2003-09-19 |
2006-06-20 |
Penwest Pharmaceuticals Co |
Delayed released dosage forms.
|
JP4593469B2
(en)
|
2003-09-22 |
2010-12-08 |
杏林製薬株式会社 |
5-aminosalicylic acid solid preparation with improved discoloration and storage method thereof
|
WO2005030173A1
(en)
|
2003-09-25 |
2005-04-07 |
Ranbaxy Laboratories Limited |
Colon-specific drug delivery using interpolymer complexations
|
JP5072364B2
(en)
|
2003-11-25 |
2012-11-14 |
スミスクライン ビーチャム (コーク) リミテッド |
Carvedilol free base, carvedilol salt, anhydrous form or solvate thereof, corresponding pharmaceutical composition, controlled release formulation and treatment or delivery method
|
EP1547601A1
(en)
|
2003-12-23 |
2005-06-29 |
Ferring B.V. |
Coating method
|
FR2872044B1
(en)
|
2004-06-28 |
2007-06-29 |
Flamel Technologies Sa |
PHARMACEUTICAL FORMULATION BASED ON ANTIBIOTICS IN THE MICROCAPSULAR FORM
|
KR100882756B1
(en)
|
2004-09-01 |
2009-02-09 |
더 프록터 앤드 갬블 캄파니 |
Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar
|
US20080020041A1
(en)
|
2004-10-19 |
2008-01-24 |
Ayres James W |
Enteric Coated Compositions that Release Active Ingredient(s) in Gastric Fluid and Intestinal Fluid
|
EP1807018A4
(en)
|
2004-10-21 |
2012-07-04 |
Univ Iowa Res Found |
In situ controlled release drug delivery system
|
US20060141054A1
(en)
|
2004-10-25 |
2006-06-29 |
Thomas Piccariello |
Metal coordinated compositions
|
DE602005007624D1
(en)
|
2004-10-28 |
2008-07-31 |
Pantec Ag |
PREPARATION OF A RAPIDLY CRUISING SOLUBLE FORMULATION BASED ON A POWDER AND A FREEZED DRYING STEP
|
FR2878159B1
(en)
|
2004-11-24 |
2008-10-17 |
Flamel Technologies Sa |
ORAL MEDICATION WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE IN MULTIMICROCAPSULAR FORM
|
US7691364B2
(en)
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
US9149439B2
(en)
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
US20090048219A1
(en)
|
2005-05-23 |
2009-02-19 |
Nitromed Inc. |
Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use
|
US20090017110A1
(en)
|
2005-05-31 |
2009-01-15 |
Capricorn Pharma Inc. |
Modified release formulations of anti-irritability drugs
|
US20060292225A1
(en)
|
2005-06-24 |
2006-12-28 |
Felix Arthur M |
Water soluble analgesic formulations and methods for production
|
EP1898886B1
(en)
|
2005-07-01 |
2019-09-04 |
Rubicon Research Pvt Ltd. |
Novel sustained release dosage form
|
US9198862B2
(en)
|
2005-07-22 |
2015-12-01 |
Rubicon Research Private Limited |
Dispersible tablet composition
|
WO2007020508A1
(en)
|
2005-08-12 |
2007-02-22 |
Ferring International Center S.A. |
Method and device for dividing granules
|
WO2007019888A2
(en)
|
2005-08-12 |
2007-02-22 |
Ctg Pharma S.R.L. |
Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
US8921344B2
(en)
|
2006-11-03 |
2014-12-30 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
UA91376C2
(en)
|
2005-08-24 |
2010-07-26 |
Рубикон Рисеч Пвт Лтд. |
Controlled release formulation
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
US9603941B2
(en)
|
2006-01-24 |
2017-03-28 |
Minghui Chai |
Method of preparing dendritic drugs
|
WO2007086039A1
(en)
|
2006-01-27 |
2007-08-02 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin |
A method of producing porous microparticles
|
JP2010500050A
(en)
|
2006-04-27 |
2010-01-07 |
シェノイ,ナルマダ,アール. |
Compositions and methods for treating or preventing diseases of body passages
|
CN101522174A
(en)
|
2006-05-10 |
2009-09-02 |
赢创德固赛有限责任公司 |
Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
|
WO2008008120A1
(en)
|
2006-07-14 |
2008-01-17 |
Fmc Corporation |
Solid form
|
WO2008013416A1
(en)
|
2006-07-27 |
2008-01-31 |
Amorepacific Corporation |
Process for preparing powder comprising nanoparticles of sparingly soluble drug
|
BRPI0622008A2
(en)
|
2006-09-13 |
2011-12-20 |
Procter & Gamble |
Treatment Methods for Ulcerative Colitis
|
US20100048519A1
(en)
|
2006-09-13 |
2010-02-25 |
Chyon-Hwa Yeh |
Methods of treatment for ulcerative colitis using aminosalicylate
|
US20080081070A1
(en)
|
2006-09-15 |
2008-04-03 |
Auriga Laboratories, Inc. |
Pharmaceutical formulation with enhanced solubility for the delivery of corticosteroids
|
WO2008056200A1
(en)
|
2006-11-10 |
2008-05-15 |
Ranbaxy Laboratories Limited |
Oral pharmaceutical compositions of simethicone
|
RU2485945C2
(en)
|
2006-11-17 |
2013-06-27 |
Шир Девелопмент Инк. |
Method of treating inflammatory intestinal diseases
|
WO2008068584A2
(en)
|
2006-12-05 |
2008-06-12 |
University Of Witwatersrand, Johannesburg |
A heterogeneously configured multiparticulate gastrointestinal drug delivery system
|
US20100136125A1
(en)
|
2006-12-28 |
2010-06-03 |
Jacobus Pharmaceutical Company, Inc. |
Method of treating inflammatory bowel disease
|
DE102007009242A1
(en)
|
2007-02-22 |
2008-09-18 |
Evonik Röhm Gmbh |
Pellets with enteric-coated matix
|
DE102007009243A1
(en)
|
2007-02-22 |
2008-09-18 |
Evonik Röhm Gmbh |
Pellets with a drug matrix and a polymer coating, and a method for producing the pellets
|
IE20070129A1
(en)
|
2007-02-28 |
2008-12-24 |
Giuliani Int Ltd |
Ppar-gamma agonists stimulate enteric defensin expression
|
US20080286343A1
(en)
|
2007-05-16 |
2008-11-20 |
Dzenana Cengic |
Solid form
|
US20080311162A1
(en)
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
WO2008140460A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
WO2008140459A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
US20080286344A1
(en)
|
2007-05-16 |
2008-11-20 |
Olivia Darmuzey |
Solid form
|
WO2008140461A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
US8217083B2
(en)
|
2007-06-08 |
2012-07-10 |
Aptalis Pharma Canada Inc. |
Mesalamine suppository
|
US7541384B2
(en)
|
2007-06-08 |
2009-06-02 |
Axcan Pharma Inc. |
Mesalamine suppository
|
US8637080B2
(en)
|
2007-06-28 |
2014-01-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Rupturing controlled release device comprising a subcoat
|
WO2009008006A2
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
US20090028944A1
(en)
|
2007-07-16 |
2009-01-29 |
Balaji Sathurappan |
Pharmaceutical compositions comprising mesalamine
|
US20090036414A1
(en)
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
PL2200588T3
(en)
|
2007-09-25 |
2019-09-30 |
Solubest Ltd. |
Compositions comprising lipophilic active compounds and method for their preparation
|
WO2009047802A2
(en)
|
2007-10-10 |
2009-04-16 |
Lupin Limited |
Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof
|
JP2011500552A
(en)
|
2007-10-10 |
2011-01-06 |
ルピン・リミテッド |
Pharmaceutical combinations and compositions for treating gastrointestinal disorders
|
WO2009148470A1
(en)
|
2007-10-25 |
2009-12-10 |
The Board Of Trustees Of Southern Illinois University |
Methods for diagnosing bowel disease
|
WO2009078872A1
(en)
|
2007-12-18 |
2009-06-25 |
Soluprin Pharmaceuticals, Inc. |
Orally disintegrating water soluble analgesic formulations and methods for production thereof
|
US20090162434A1
(en)
|
2007-12-21 |
2009-06-25 |
Disphar International Bv |
Mesalazine tablet
|
ITMI20072429A1
(en)
|
2007-12-24 |
2009-06-25 |
Giuliani Int Ltd |
COMPOUNDS FOR THE SELECTIVE TREATMENT OF THE INTESTINAL IMMUNE-INFLAMMATORY COMPONENT OF THE CELIAC DISEASE
|
US20090169622A1
(en)
|
2007-12-27 |
2009-07-02 |
Roxane Laboratories, Inc. |
Delayed-release oral pharmaceutical composition for treatment of colonic disorders
|
AU2009203627A1
(en)
|
2008-01-11 |
2009-07-16 |
Cipla Limited |
Solid pharmaceutical dosage form
|
EP2133071A1
(en)
|
2008-06-09 |
2009-12-16 |
Université de la Méditerranée |
Process for making gastroretentive dosage forms
|
WO2009150530A2
(en)
|
2008-06-11 |
2009-12-17 |
Ferring International Center Sa |
Novel foam composition
|
EP2135601A1
(en)
|
2008-06-20 |
2009-12-23 |
Capsulution Nanoscience AG |
Stabilization of amorphous drugs using sponge-like carrier matrices
|
WO2009158384A1
(en)
|
2008-06-27 |
2009-12-30 |
The Procter & Gamble Company |
Methods and kits for the treatment inhibition, and maintenance of gastrointestinal disorders
|
US20090326069A1
(en)
|
2008-06-30 |
2009-12-31 |
Bltn, Llc |
Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers
|